Loblaw sets itself apart from rivals

Article Excerpt

Loblaw continues to report rising sales and earnings—and it now plans to use that strength to spend $1 billion to open new stores and upgrade existing locations. The stock is trading close to all-time highs for us, but we still see it as a safety-conscious buy. LOBLAW COMPANIES $70.28 (Toronto symbol L; Shares outstanding: 410.2 million; Market cap: $28.3 billion; TSINetwork Rating: Above Average; Dividend yield: 1.5%; www.loblaw.ca) currently operates over 1,100 supermarkets and 1,300 Shopper Drug Mart pharmacies across Canada. In the three months ended March 26, 2016, Loblaw earned $338 million, or $0.82 a share. That’s up 12.3% from $301 million, or $0.72, a year earlier. Sales rose 4.8%, to $13.9 billion from $13.6 billion. Excluding gas station revenue, same-store sales rose 2.6% at Loblaw. They rose 6.3% at Shoppers Drug Mart. The company now plans to spend $1 billion to open 50 new locations and renovate 150 stores. Choice Properties REIT (Toronto symbol CHP.UN) will contribute an additional…